Indomethacin (CAS 53-86-1) — formula C19H16ClNO4, molecular weight 357.8; category organic chemicals.
| CAS Number | 53-86-1 |
|---|---|
| Molecular Formula | C19H16ClNO4 |
| Molecular Weight | 357.8 |
| Melting Point | 311 or 323.6 °F (NTP, 1992) |
| LogP | 4.27 |
| Applications | Uses: MEDICATION, Anti-Inflammatory Agents, Non-Steroidal, Cardiovascular Agents, Cyclooxygenase Inhibitors, Gout Suppressants, Tocolytic Agents, Use (kg) in Switzerland (2009): >100, Use (kg, approx.) in Germany (2009): >1000, Use (kg) in USA (2002): 4630, Consumption (g per capita) in Switzerland (2009): 0.013, Consumption (g per capita, approx.) in Germany (2009): 0.012, Consumption (g per capita) in the USA (2002): 0.016, Excretion rate: 0.275, Calculated removal (%): 78.5, For moderate to severe rheumatoid arthritis including acute flares of chronic disease, ankylosing spondylitis, osteoarthritis, acute painful shoulder (bursitis and, or tendinitis) and acute gouty arthritis., Use Classification: Pharmaceuticals, Methods of Manufacturing: p-Anisidine + ethyl levulinate + p-chlorobenzoyl chloride (diazotisation, hydrogenation, Fischer indole synthesis, amide formation, saponification)., Acylation of sodium 2-(4-methoxy-phenyl)hydrazine-1-sulfonate with 4-chlorobenzoyl chloride followed by heating yields 1-(4- chlorobenzoyl)-1-(4-methoxyphenyl)hydrazine. Condensation with levulinic acid in a Fischer indole synthesis affords indomethacin., Formulations, Preparations: Table: Indomethacin Preparations [Table#4437], Table: Indomethacin Sodium Preparations [Table#4438], General Manufacturing Information: 1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-: ACTIVE, TRANSDERMAL INDOMETHACIN PHARMACEUTICALS CONTAIN POLYOXYETHYLENE ALKYL ETHERS AND, OR POLYOXYETHYLENE ALKYLPHENYL ESTERS (WHICH ARE LIQ AT 25 DEG) AND ACRYLIC ADHESIVES. |
| Category | Organic Chemicals |
Documented applications: Uses: MEDICATION, Anti-Inflammatory Agents, Non-Steroidal, Cardiovascular Agents, Cyclooxygenase Inhibitors, Gout Suppressants, Tocolytic Agents, Use (kg) in Switzerland (2009): >100, Use (kg, approx.) in Germany (2009): >1000, Use (kg) in USA (2002): 4630, Consumption (g per capita) in Switzerland (2009): 0.013, Consumption (g per capita, approx.) in Germany (2009): 0.012, Consumption (g per capita) in the USA (2002): 0.016, Excretion rate: 0.275, Calculated removal (%): 78.5, For moderate to severe rheumatoid arthritis including acute flares of chronic disease, ankylosing spondylitis, osteoarthritis, acute painful shoulder (bursitis and, or tendinitis) and acute gouty arthritis., Use Classification: Pharmaceuticals, Methods of Manufacturing: p-Anisidine + ethyl levulinate + p-chlorobenzoyl chloride (diazotisation, hydrogenation, Fischer indole synthesis, amide formation, saponification)., Acylation of sodium 2-(4-methoxy-phenyl)hydrazine-1-sulfonate with 4-chlorobenzoyl chloride followed by heating yields 1-(4- chlorobenzoyl)-1-(4-methoxyphenyl)hydrazine. Condensation with levulinic acid in a Fischer indole synthesis affords indomethacin., Formulations, Preparations: Table: Indomethacin Preparations [Table#4437], Table: Indomethacin Sodium Preparations [Table#4438], General Manufacturing Information: 1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-: ACTIVE, TRANSDERMAL INDOMETHACIN PHARMACEUTICALS CONTAIN POLYOXYETHYLENE ALKYL ETHERS AND, OR POLYOXYETHYLENE ALKYLPHENYL ESTERS (WHICH ARE LIQ AT 25 DEG) AND ACRYLIC ADHESIVES..
Indomethacin is a carbon-based organic compound with CAS registry number 53-86-1 and molecular formula C19H16ClNO4 (molecular weight 357.8), belonging to the organic chemicals segment of chemical raw materials.
CAS number: 53-86-1
Its molecular formula C19H16ClNO4 comprises 19 C, 16 H, 1 Cl, 1 N, 4 O atoms.
Also known as: Indomethacin · 消炎痛
Category: organic chemicals
The CAS registry number of Indomethacin is 53-86-1.
Molecular formula C19H16ClNO4, molecular weight 357.8.
It is also registered under: Indomethacin, 消炎痛.
Recorded applications: Uses: MEDICATION, Anti-Inflammatory Agents, Non-Steroidal, Cardiovascular Agents, Cyclooxygenase Inhibitors, Gout Suppressants, Tocolytic Agents, Use (kg) in Switzerland (2009): >100, Use (kg, approx.) in Germany (2009): >1000, Use (kg) in USA (2002): 4630, Consumption (g per capita) in Switzerland (2009): 0.013, Consumption (g per capita, approx.) in Germany (2009): 0.012, Consumption (g per capita) in the USA (2002): 0.016, Excretion rate: 0.275, Calculated removal (%): 78.5, For moderate to severe rheumatoid arthritis including acute flares of chronic disease, ankylosing spondylitis, osteoarthritis, acute painful shoulder (bursitis and, or tendinitis) and acute gouty arthritis., Use Classification: Pharmaceuticals, Methods of Manufacturing: p-Anisidine + ethyl levulinate + p-chlorobenzoyl chloride (diazotisation, hydrogenation, Fischer indole synthesis, amide formation, saponification)., Acylation of sodium 2-(4-methoxy-phenyl)hydrazine-1-sulfonate with 4-chlorobenzoyl chloride followed by heating yields 1-(4- chlorobenzoyl)-1-(4-methoxyphenyl)hydrazine. Condensation with levulinic acid in a Fischer indole synthesis affords indomethacin., Formulations, Preparations: Table: Indomethacin Preparations [Table#4437], Table: Indomethacin Sodium Preparations [Table#4438], General Manufacturing Information: 1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-: ACTIVE, TRANSDERMAL INDOMETHACIN PHARMACEUTICALS CONTAIN POLYOXYETHYLENE ALKYL ETHERS AND, OR POLYOXYETHYLENE ALKYLPHENYL ESTERS (WHICH ARE LIQ AT 25 DEG) AND ACRYLIC ADHESIVES..
Category: Organic Chemicals.
Independent reference data for Indomethacin (CAS 53-86-1), compiled from public chemistry databases.
| CAS Registry Number | 53-86-1 |
|---|---|
| PubChem CID | 3715 |
| Molecular formula | C19H16ClNO4 |
| IUPAC name | 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid |
| UNII (FDA) | XXE1CET956 |
| Molecular Weight | 357.8 |
|---|---|
| XLogP3 | 4.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Exact Mass | 357.0767857 |
| Monoisotopic Mass | 357.0767857 |
| Topological Polar Surface Area | 68.5 |
| Heavy Atom Count | 25 |
| Melting Point | 311 or 323.6 °F (NTP, 1992) |
|---|---|
| Melting Point | 151 |
| Melting Point | MP: 160 °C |
| Melting Point | 158 °C |
| Solubility | 0.937 |
| Solubility | In water, 0.937 mg/L at 25 °C |
| Solubility | 2.40e-03 g/L |
| LogP | 4.27 |
| LogP | 3.4 |
| LogP | 3.86 |
indomethacin; 53-86-1; indometacin; Indomethacine; Indometacine; Indocid; Metindol; Reumacide; Indomethazine; Idomethine; Imbrilon; Mikametan; Indacin; Mobilan; Tannex; Amuno
| Reported hazard statements | H300 (81%), H301 (19%), H317 (24.9%), H318 (18.5%), H335 (18.5%), H336 (18.5%), H360 (25.4%), H373 (19%) |
|---|
H300 (81%): Fatal if swallowed [Danger Acute toxicity, oral]
H301 (19%): Toxic if swallowed [Danger Acute toxicity, oral]
Indomethacin · CAS 53-86-1 · C19H16ClNO4. UNII XXE1CET956. Melting Point: 311 or 323.6 °F (NTP, 1992); Melting Point: 151; Melting Point: MP: 160 °C.
Source: PubChem / Wikidata; the batch COA governs where values differ.
Supplier: Jinan Shenghe Chemical Co., Ltd.
中文页面: 消炎痛